Compare HIMX & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HIMX | TNDM |
|---|---|---|
| Founded | 2001 | 2006 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2006 | 2013 |
| Metric | HIMX | TNDM |
|---|---|---|
| Price | $8.39 | $19.91 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 17 |
| Target Price | N/A | ★ $24.06 |
| AVG Volume (30 Days) | 890.2K | ★ 1.2M |
| Earning Date | 02-12-2026 | 02-19-2026 |
| Dividend Yield | ★ 4.39% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | $866,315,000.00 | ★ $1,007,001,000.00 |
| Revenue This Year | N/A | $8.59 |
| Revenue Next Year | $8.35 | $10.19 |
| P/E Ratio | $23.65 | ★ N/A |
| Revenue Growth | N/A | ★ 17.87 |
| 52 Week Low | $5.66 | $9.98 |
| 52 Week High | $13.91 | $37.93 |
| Indicator | HIMX | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 50.16 | 39.60 |
| Support Level | $8.15 | $19.61 |
| Resistance Level | $8.86 | $21.64 |
| Average True Range (ATR) | 0.32 | 1.24 |
| MACD | 0.01 | -0.32 |
| Stochastic Oscillator | 33.91 | 6.91 |
Himax Technologies Inc is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The majority of the firm's revenue is derived from the Driver Integrated Circuit segment. It offers display driver ICs and timing controllers used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, virtual reality (VR) devices, and many other consumer electronics devices. It also designs and provides controllers for touch sensor displays, in-cell Touch and Display Driver Integration single-chip solutions, LED driver ICs, power management ICs, and scaler products for monitors and projectors. Geographically, it generates the majority of its revenue from China.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.